TumCMig Cancer Research Results
TumCMig, Tumor cell migration: Click to Expand ⟱
| Source: |
| Type: |
Tumor cell migration is a critical process in cancer progression and metastasis, which is the spread of cancer cells from the primary tumor to distant sites in the body.
|
NSCLC, Non-small Cell Lung Cancer: Click to Expand ⟱
Non-small Cell Lung Cancer
|
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
NSCLC, |
A549 |
|
|
|
- |
vitro+vivo, |
NSCLC, |
H1299 |
|
|
|
TumCCA↑, CSCs↓, TumCI↓, TumCMig↓, TumCG↓, Wnt/(β-catenin)↓, Nanog↓, SOX2↓, OCT4↓, N-cadherin↓, Vim↓, E-cadherin↑,
TumCMig↓, TumCI↓, PI3K↓, Akt↓, MDM2↓, TumCP↓, TumMeta↓,
TumCMig↓, TumCP↓, Apoptosis↑, TFAP2A↓, hTERT/TERT↓, NF-kB↓, COX2↓, Hif1a↓, VEGF↓, Akt↓, p‑ERK↓, Cyt‑c↑, cl‑Casp↑, cl‑PARP↑, PI3K↓, Akt↓, Raf↓, MEK↓, ERK↓,
| - |
in-vitro, |
NSCLC, |
Calu-1 |
|
|
|
TumCP↓, PCNA↓, Ki-67↓, MCM2↓, Bcl-2↓, BAX↑, cl‑Casp3↑, TumCMig↓, TumCI↓, Hif1a↓, VEGF↓,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Mitochondria & Bioenergetics ⓘ
MEK↓, 1, Raf↓, 1,
Cell Death ⓘ
Akt↓, 3, Apoptosis↑, 1, BAX↑, 1, Bcl-2↓, 1, cl‑Casp↑, 1, cl‑Casp3↑, 1, Cyt‑c↑, 1, hTERT/TERT↓, 1, MDM2↓, 1,
DNA Damage & Repair ⓘ
cl‑PARP↑, 1, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
TFAP2A↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
CSCs↓, 1, ERK↓, 1, p‑ERK↓, 1, MCM2↓, 1, Nanog↓, 1, OCT4↓, 1, PI3K↓, 2, SOX2↓, 1, TumCG↓, 1, Wnt/(β-catenin)↓, 1,
Migration ⓘ
E-cadherin↑, 1, Ki-67↓, 1, N-cadherin↓, 1, TumCI↓, 3, TumCMig↓, 4, TumCP↓, 3, TumMeta↓, 1, Vim↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 2, VEGF↓, 2,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, NF-kB↓, 1,
Clinical Biomarkers ⓘ
hTERT/TERT↓, 1, Ki-67↓, 1,
Total Targets: 39
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: TumCMig, Tumor cell migration
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:19 Cells:% prod#:% Target#:326 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page